Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 5, 2006, Pages 648-652

  Zhu, J H ^a   Chen, J Z ^a   Wang, X X ^a   Xie, X D ^a   Sun, J ^a   Zhang, F R ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Akt protein kinase B; Endothelial progenitor cells; Homocysteine; Senescence; Telomerase

Indexed keywords

ATORVASTATIN; BETA GALACTOSIDASE; HOMOCYSTEINE; PROTEIN KINASE B; TELOMERASE;

ARTICLE; BIOACCUMULATION; CELL ACTIVITY; CELL AGING; CELL FUNCTION; CELL ISOLATION; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOLOGY; DEPHOSPHORYLATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; MEASUREMENT; MOLECULAR BIOLOGY; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SENESCENCE; STATISTICAL SIGNIFICANCE; STEM CELL; WESTERN BLOTTING;

BETA-GALACTOSIDASE; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL AGING; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HOMOCYSTEINE; HUMANS; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; STEM CELLS; TELOMERASE;

EID: 33646101264     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.01.011     Document Type: Article

References (21)

1. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003) 593-600
2. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 275 (1997) 964-967
4. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
5. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438
6. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
7. Chen J.Z., Zhu J.H., Wang X.X., Zhu J.H., Xie X.D., Sun J., et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J. Mol. Cell. Cardiol. 36 (2004) 233-239
8. Assmus B., Urbich C., Aicher A., Hofmann W.K., Haendeler J., Rossig L., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ. Res. 92 (2003) 1049-1055
9. Imanishi T., Hano T., Sawamura T., and Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin. Exp. Pharmacol. Physiol. 31 (2004) 407-413
10. Mathon N.F., and Lloyd A.C. Cell senescence and cancer. Nat. Rev. Cancer 1 (2001) 203-213
11. Greider C.W. Telomeres, telomerase and senescence. Bioessays 12 (1990) 363-369
12. Murasawa S., Llevadot J., Silver M., Isner J.M., Losordo D.W., and Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106 (2002) 1133-1139
13. Xu D., Neville R., and Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett. 470 (2000) 20-24
14. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001) E1-E7
15. Zhu J.H., Wang X.X., Chen J.Z., Shang Y.P., Zhu J.H., Guo X.G., et al. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol. Sin. 25 (2004) 1045-1051
16. Kim N.W., and Wu F. [TRAP] Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol. Nucleic Acids Res. 25 (1997) 2595-2597
17. Benndorf R., Boger R.H., Ergun S., Steenpass A., and Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ. Res. 93 (2003) 438-447
18. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92 (1995) 9363-9367
19. Breitschopf K., Zeiher A.M., and Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 493 (2001) 21-25
20. Kang S.S., Kwon T., Kwon D.Y., and Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274 (1999) 13085-13090
21. Vasa M., Breitschopf K., Zeiher A.M., and Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 87 (2000) 540-542